Unaudited Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Cash flows from operating activities
Net loss	$ (234,588)	$ (347,947)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization expense	53,504	27,673
Stock-based compensation	2,252	8,906
Lease impairment loss	7,673	0
Loss on disposal of property, plant and equipment	2,511	3,698
Change in fair value of related party notes payable and related party warrant liabilities	(315)	(5,110)
Change in fair value of notes payable and warrant liabilities	(28,927)	(90,461)
Change in fair value measurement of earnout liability	0	1,381
Amortization of operating lease right-of-use asset	1,947	2,491
Loss on foreign exchange	(40)	218
Non-cash interest expense	2,030	0
Settlement on accrued research and development expenses	(14,935)	0
Other	366	1,416
Changes in operating assets and liabilities:
Deposits	1,157	(19,237)
Inventory	6,949	(30,758)
Other current and non-current assets	7,554	(3,415)
Accounts payable	(1,736)	13,838
Financial obligations on sale and lease back transaction	1,976	0
Accrued expenses and other current liabilities	3,612	(23,332)
Operating lease liabilities	(2,134)	(1,838)
Accrued related party interest expense	7,544	(26)
Net cash used in operating activities	(51,796)	(240,370)
Cash flows from investing activities
Proceeds from sale of equipment	87	0
Purchase of property, plant and equipment	(659)	(10,846)
Net cash used in investing activities	(572)	(10,846)
Cash flows from financing activities
Proceeds from sale of Common Stock, net of issuance costs	0	8,520
Proceeds from exercise of warrants	0	4,074
Payments of notes payable	(101)	0
Payments of finance lease obligations	0	(1,016)
Proceeds from exercise of stock options	0	44
Net cash provided by financing activities	55,685	237,565
Effect of exchange rate changes on cash and restricted cash	7	3,704
Net change in cash and restricted cash	3,324	(9,947)
Cash and restricted cash, beginning of period	4,025	18,514
Cash and restricted cash, end of period	7,349	8,567
Cash and restricted cash
Cash	7,269	6,714
Restricted cash	80	1,853
Total cash and restricted cash	7,349	8,567
Supplemental disclosure of noncash investing and financing activities
Additions of property, plant and equipment included in accounts payable and accrued expenses	45,455	34,124
Conversion of notes payable, related party notes payable and accrued interest into Class A Common Stock (as restated)	44,891	125,327
Issuance of SPA Warrants and Junior SPA Warrants	17,194	34,257
Reclassification of earnout shares from equity to liability on April 21, 2023 due to insufficient authorized shares	0	2,112
Reclassification of stock-based awards from equity to liability on April 21, 2023 due to insufficient authorized shares	0	2,979
Issuance of exchange note	0	16,500
Reclassification of warrants from equity to liability	0	6,811
Reduction in warrants pursuant to the Exchange Agreement	0	16,506
Purchase of Class A Common Stock under the Salary Deduction and Stock Purchase Agreements	36	0
RSU tax withholdings	10	0
Supplemental disclosure of noncash operating activities
Settlement of Palantir dispute with issuance of Class A Common Stock	2,400	0
Supplemental disclosure of cash flow information
Cash paid for interest	2,988	465
February 28, 2023
Supplemental disclosure of noncash investing and financing activities
Reclassification of stock-based awards from liability to equity due to authorized share increase	0	8,978
Reclassification of earnout shares from liability to equity due to authorized share increase	0	5,014
August 25, 2023
Supplemental disclosure of noncash investing and financing activities
Reclassification of stock-based awards from liability to equity due to authorized share increase	0	2,043
Reclassification of earnout shares from liability to equity due to authorized share increase	0	1,381
Nonrelated Party
Adjustments to reconcile net loss to net cash used in operating activities:
Loss on settlement of notes payable	117,509	204,885
Cash flows from financing activities
Proceeds from notes payable, net of original issuance discount	54,021	208,650
Settlement of notes payable transaction costs	(1,310)	(2,489)
Related Party
Adjustments to reconcile net loss to net cash used in operating activities:
Loss on settlement of notes payable	14,295	17,248
Cash flows from financing activities
Proceeds from related party notes payable	$ 3,075	$ 19,782